Cargando…

Metabolic effects of bezafibrate in mitochondrial disease

Mitochondrial disorders affect 1/5,000 and have no cure. Inducing mitochondrial biogenesis with bezafibrate improves mitochondrial function in animal models, but there are no comparable human studies. We performed an open‐label observational experimental medicine study of six patients with mitochond...

Descripción completa

Detalles Bibliográficos
Autores principales:	Steele, Hannah, Gomez‐Duran, Aurora, Pyle, Angela, Hopton, Sila, Newman, Jane, Stefanetti, Renae J, Charman, Sarah J, Parikh, Jehill D, He, Langping, Viscomi, Carlo, Jakovljevic, Djordje G, Hollingsworth, Kieren G, Robinson, Alan J, Taylor, Robert W, Bottolo, Leonardo, Horvath, Rita, Chinnery, Patrick F
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2020
Materias:	Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7059007/ https://www.ncbi.nlm.nih.gov/pubmed/32107855 http://dx.doi.org/10.15252/emmm.201911589

Ejemplares similares

High intensity intermittent exercise improves cardiac structure and function and reduces liver fat in patients with type 2 diabetes: a randomised controlled trial
por: Cassidy, Sophie, et al.
Publicado: (2015)

Measurement of pulse wave velocity in normal ageing: comparison of Vicorder and magnetic resonance phase contrast imaging
por: Parikh, Jehill D., et al.
Publicado: (2016)

Normal age-related changes in left ventricular function: Role of afterload and subendocardial dysfunction
por: Parikh, Jehill D., et al.
Publicado: (2016)

Left ventricular functional, structural and energetic effects of normal aging: Comparison with hypertension
por: Parikh, Jehill D., et al.
Publicado: (2017)

Therapy of Canine Hyperlipidemia with Bezafibrate
por: De Marco, V., et al.
Publicado: (2017)

Bezafibrate for X-Linked Adrenoleukodystrophy
por: Engelen, Marc, et al.
Publicado: (2012)

Variations in right atrial flow patterns in the normal heart a potential contributor to cryptogenic stroke in the setting of patent foramen ovale
por: Parikh, Jehill D, et al.
Publicado: (2015)

4D flow MRI assessment of right atrial flow patterns in the normal heart – influence of caval vein arrangement and implications for the patent foramen ovale
por: Parikh, Jehill D., et al.
Publicado: (2017)

Update on the use of fibrates: focus on bezafibrate
por: Goldenberg, Ilan, et al.
Publicado: (2008)

Bezafibrate Improves Mitochondrial Fission and Function in DNM1L-Deficient Patient Cells
por: Douiev, Liza, et al.
Publicado: (2020)

Concentric hypertrophic remodelling and subendocardial dysfunction in mitochondrial DNA point mutation carriers(†)
por: Bates, Matthew G.D., et al.
Publicado: (2013)

A novel cardiac output response to stress test developed to improve diagnosis and monitoring of heart failure in primary care
por: Charman, Sarah J., et al.
Publicado: (2018)

Expanding the phenotype of de novo SLC25A4-linked mitochondrial disease to include mild myopathy
por: King, Martin S., et al.
Publicado: (2018)

Antidiabetic Action of Bezafibrate in a Large Observational Database
por: Flory, James H., et al.
Publicado: (2009)

I-3 Treatment of CPT2 deficiency with bezafibrate
por: Laforet, P.
Publicado: (2011)

Bezafibrate prevents aging in in vitro-matured porcine oocytes
por: Kim, Ju-Yeon, et al.
Publicado: (2021)

Effect of the lipid-lowering agent bezafibrate on tumour growth rate in vivo.
por: Mulligan, H. D., et al.
Publicado: (1991)

Investigation of novel material for effective photodegradation of bezafibrate in aqueous samples
por: Regulska, Elżbieta, et al.
Publicado: (2014)

Bezafibrate Attenuates Pressure Overload-Induced Cardiac Hypertrophy and Fibrosis
por: Xu, Si-Chi, et al.
Publicado: (2017)

Efficacy of bezafibrate in two patients with mitochondrial trifunctional protein deficiency
por: Suyama, Tomonori, et al.
Publicado: (2020)

Bezafibrate Reduces Elevated Hepatic Fumarate in Insulin-Deficient Mice
por: Franko, Andras, et al.
Publicado: (2022)

Altered 2-thiouridylation impairs mitochondrial translation in reversible infantile respiratory chain deficiency
por: Boczonadi, Veronika, et al.
Publicado: (2013)

Bezafibrate lowers very long-chain fatty acids in X-linked adrenoleukodystrophy fibroblasts by inhibiting fatty acid elongation
por: Engelen, Marc, et al.
Publicado: (2012)

Combined Bezafibrate and Medroxyprogesterone Acetate: Potential Novel Therapy for Acute Myeloid Leukaemia
por: Khanim, Farhat L., et al.
Publicado: (2009)

Myocardial capillary density in normal and diabetic male rats: Effect of bezafibrate
por: Khazaei, M, et al.
Publicado: (2013)

Expression Profiling Identifies Bezafibrate as Potential Therapeutic Drug for Lung Adenocarcinoma
por: Liu, Xinyan, et al.
Publicado: (2015)

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis
por: Yin, Qin, et al.
Publicado: (2015)

Cessation of Bezafibrate in patients with chronic kidney disease improves renal function
por: Zingerman, Boris, et al.
Publicado: (2020)

Cardiac structure and function are altered in type 2 diabetes and Non-alcoholic fatty liver disease and associate with glycemic control
por: Cassidy, Sophie, et al.
Publicado: (2015)

OPA1 mutations impair mitochondrial function in both pure and complicated dominant optic atrophy
por: Yu-Wai-Man, Patrick, et al.
Publicado: (2011)

Recent advances in understanding the role of FOXO3
por: Stefanetti, Renae J., et al.
Publicado: (2018)

Systematic review and meta-analysis: bezafibrate in patients with primary biliary cirrhosis [Erratum]
Publicado: (2015)

Bezafibrate Exerts Neuroprotective Effects in a Rat Model of Sporadic Alzheimer’s Disease
por: Lin, Li-Fan, et al.
Publicado: (2022)

Bezafibrate Enhances AAV Vector-Mediated Genome Editing in Glycogen Storage Disease Type Ia
por: Kang, Hye-Ri, et al.
Publicado: (2019)

Skeletal muscle mitochondrial oxidative phosphorylation function in idiopathic pulmonary arterial hypertension: in vivo and in vitro study
por: Sithamparanathan, Sasiharan, et al.
Publicado: (2018)

A novel pathogenic m.4412G>A MT-TM mitochondrial DNA variant associated with childhood-onset seizures, myopathy and bilateral basal ganglia changes
por: Lim, Albert Z., et al.
Publicado: (2019)

Impact of age on the association between cardiac high-energy phosphate metabolism and cardiac power in women
por: Nathania, Maria, et al.
Publicado: (2018)

Angioscopic Evaluation of Stabilizing Effects of Bezafibrate on Coronary Plaques in Patients With Coronary Artery Disease
por: Uchida, Yasumi, et al.
Publicado: (2000)

Dual and pan-peroxisome proliferator-activated receptors (PPAR) co-agonism: the bezafibrate lessons
por: Tenenbaum, Alexander, et al.
Publicado: (2005)

Effects of bezafibrate on lipid and glucose metabolism in dyslipidemic patients with diabetes: the J-BENEFIT study
por: Teramoto, Tamio, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_vfqvfdb3u10f7udvkh65k9387n